ClinicalTrials.gg
Status unknownNCT04176874PROMA1Updated Mar 3, 2023

Abdominal Diastasis Repair by Robotic Surgery

An observational study in Diastasis of Muscle, Other Site, sponsored by Assistance Publique - Hôpitaux de Paris. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-03.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

How we know

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

The objective of the study is to evaluate the feasibility of a robot-assisted minimally invasive surgical technique for the management of diastasis of the rectus abdominis. The effectiveness of this robotic surgery will be evaluated on the intermuscular distance measurement above and under umbilicus using ultrasound or CT-scan imaging.

Read the detailed description

This is a bi-centric, prospective, regional research.

Patients will be included in the:

  • Henri Mondor University Hospital in Créteil, in the plastic and reconstructive surgery department headed by Professor Meningaud.
  • Tenon University Hospital in Paris in the plastic and reconstructive surgery department of Dr. Atlan.

As part of this research, subjects will be identified as follows:

center number (3 numeric positions) - person selection order number in the center (4 numeric positions) - initial last name - initial first name This reference is unique and will be kept for the duration of the search.

A recruitment of 50 subjects is planned. (The investigator and/or monitor) will gradually complete a form, "Pre-included Patient Register", which will include all patients (initial and date of birth) who were approached to enter the study, whether finally included or not, as well as the reasons for not including them.

Patients meeting the following criteria cannot be included:

  • Patients participating or having participated in the last two months in another clinical study
  • Pregnant or breastfeeding patients
  • Patients not using contraception
  • Patients with umbilical hernia (hernia bag)
  • Patients with a history of abdominal surgery by median laparotomy
  • Patients with contraindications to general anesthesia
  • Any other reason that, in the investigator's opinion, could interfere with the proper conduct of the study

The trial includes: an inclusion visit, a surgical hospitalization and two follow-up visits

An initial inclusion visit,[VI], which allows you to:

  • check the inclusion and non-inclusion criteria explain and give consent to the patient's research participation (which will be retrieved the day before the intervention)
  • carry out the ultrasound or CT-scan for the diagnosis of diastasis.

Parameters collected during this visit

  • Physical examination
  • Patient's medical history relevant to the trial
  • Verification of compliance with inclusion and exclusion criteria
  • Ultrasound or CT-scan for the diagnosis of diastasis
  • Preoperative photographic plate

The surgical procedure is performed in a single step, under general anesthesia with the assistance of the Intuitiv SI robot. The patient is placed in supine position, with his arms along his body, in the Trendelenburg position with his legs down.

An antibioprophylaxis with Amoxicillin/clavulanic acid 1g/200mg IV is administered at induction.

Preoperative marking is performed to identify the palpated medial edges of the rectus abdominis, semilunar lines and costal awnings.

Three trocars are placed: a 12mm trocar, 2 to 3 fingertips above the pubis, median for the optics, a 8mm trocar in the right iliac fossa and a 8mm trocar in the left iliac fossa. Dissection is started with the finger or foam tip scissors through the opening of the median trocar to ensure that it is in the preaponeurotic plane, in front of the anterior sheath of the large rectus abdominis muscles.

The middle trocar is set up for the robot optics and insufflation of 13 mmHg CO2. The instrument trocars are then placed (8 or 5 mm depending on the robot : 8 mm for the Intuitiv Si robot). The preaponeurotic space is dissected in front of the anterior fascia of the rectus muscles to expose the white line to the umbilicus. The umbilicus is severed, it remains vascularized by the dermal network.

Then the dissection of the preaponeurotic space is continued to the xyphoid. Lateral dissection should not go more than 3cm beyond the semi lunar lines to maintain skin vascularization, limit dead spaces and seroma formation.

The anterior aponeuroses of the great rectus muscles are plicaturized by toothed wire (type QUILL PDO) from the suspubic region to the xyphoid. The umbilicus is attached to the fascia.

A redon or Blake drain 10 is placed through one of the 8mm holes. An abdominal compression dressing is applied at the end of the procedure.

Regarding surgical management and post-operative follow-up, the following parameters will be collect:

  • Duration of the intervention
  • Duration of hospitalization
  • Drainage time
  • Weight of skin resection in case of associated excess skin fat
  • Occurrence of post-operative complications: seromas, haematomas, infections, thromboembolic complications, scarring disorders

Follow-up visits will take place at 1,3 and 6 months after the intervention:

They will consist of:

  • an interrogation of the patient,
  • the performing of:

    • a clinical examination,
    • photographs of the face and profile of the scar
    • an abdominal ultrasound. Abdominal ultrasound was used to measure the intermuscular distance at three points (xyphoid, 3 cm above and below the umbilicus, 2 cm below the umbilicus). The average intermuscular distance was calculated from these three measurements
    • a qualitative evaluation of the scar using the VAS and POSAS scale (secondary criteria)
    • a patient satisfaction assessment using VAS scale.

The main efficacy criterion is the average intermuscular distance at 3 months post-operatively obtained by averaging ultrasound measurements at the three abdominal points defined by Beer.

The secondary efficacy criteria are:

  • Duration of the procedure, duration of hospitalization, duration of post-operative drainage
  • Occurrence of post-operative complications (seroma or hematoma collection, thromboembolic accident, infection, scarring disorders)
  • Evaluation of the scar quality evaluated by the POSAS scale
  • Overall patient satisfaction with the intervention and outcome (VAS 0 to 10)
02

Conditions studied

  • Diastasis of Muscle, Other Site

Browse trials for

Keywords

  • Diastasis recti
  • Rectus abdominis diastasis
  • Robotic surgical procedure
03

In context

Diastasis, Muscle

7 studies on the registry are indexed under Diastasis, Muscle; 3 are open to participants now.

Browse Diastasis, Muscle studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,598 studies on the registry; 1,038 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patient 18 years old or older with an indication for diastasis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient 18 years old or older with an indication for diastasis
  • Patient who has given his or her non-opposition to participation in the research
  • Patient able to understand the requirements of the trial

Exclusion criteria

Exclusion Criteria:

  • Patients participating or having participated in the last two months in another clinical study
  • Pregnant or breastfeeding patients
  • Patients not using
  • Patients with umbilical hernia (hernia bag)
  • Patients with a history of abdominal surgery by median laparotomy
  • Patients with to general anesthesia
  • Any other reason that, in the investigator's opinion, could interfere with the proper conduct of the study
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • Diastasis of the rectus abdominis muscles

    Diastasis of the rectus abdominis muscles repair using the Intuitiv SI robot

    Procedure: Robotic-assisted diastasis of the rectus abdominis muscles repair

Interventions

  • ProcedureRobotic-assisted diastasis of the rectus abdominis muscles repair

    Diastasis of the rectus abdominis muscles repair using the Intuitiv SI robot

06

What researchers measure

Primary outcomes

  1. Average intermuscular distance

    Average intermuscular distance post-operatively obtained by averaging ultrasound measurements at the three abdominal points defined by Beer.

    Time frame: At 3 months post surgery

Secondary outcomes

  1. Surgery

    Duration of the procedure

    Time frame: During the surgery

  2. Hospitalization

    Duration of hospitalization

    Time frame: Up to 4 days

  3. Drainage

    Duration of post-operative drainage

    Time frame: Up to 2 days

  4. Complications at 1 month

    Occurrence of post-operative complications at 1 month

    Time frame: At 1 month

  5. Complications at 3 months

    Occurrence of post-operative complications at 3 months

    Time frame: At 3 months

  6. Complications at 6 months

    Occurrence of post-operative complications at 6 months

    Time frame: At 6 months

  7. Scar quality at 1 month post surgery

    Evaluation of the scar quality by the POSAS scale

    Time frame: at 1 months

  8. Scar quality at 3 months post surgery

    Evaluation of the scar quality by the POSAS scale

    Time frame: at 3 months

  9. Scar quality at 6 months post surgery

    Evaluation of the scar quality by the POSAS scale

    Time frame: at 6 months

  10. Patient satisfaction at 1 month post surgery

    Overall patient satisfaction with the intervention and outcome

    Time frame: At 1 month

  11. Patient satisfaction at 3 months post surgery

    Overall patient satisfaction with the intervention and outcome

    Time frame: At 3 months

  12. Patient satisfaction at 6 months post surgery

    Overall patient satisfaction with the intervention and outcome

    Time frame: At 6 months

07

Study locations

1 of 1 sites recruiting
  • Hopital Henri Mondor
    Créteil, Val De Marne 94000, France
    Recruiting
    • Barbara Hersant · Contact
08

References and documents

Publications

  • Mommers EHH, Ponten JEH, Al Omar AK, de Vries Reilingh TS, Bouvy ND, Nienhuijs SW. The general surgeon's perspective of rectus diastasis. A systematic review of treatment options. Surg Endosc. 2017 Dec;31(12):4934-4949. doi: 10.1007/s00464-017-5607-9. Epub 2017 Jun 8. PubMed 28597282 ↗
  • Sperstad JB, Tennfjord MK, Hilde G, Ellstrom-Engh M, Bo K. Diastasis recti abdominis during pregnancy and 12 months after childbirth: prevalence, risk factors and report of lumbopelvic pain. Br J Sports Med. 2016 Sep;50(17):1092-6. doi: 10.1136/bjsports-2016-096065. Epub 2016 Jun 20. PubMed 27324871 ↗
  • Akram J, Matzen SH. Rectus abdominis diastasis. J Plast Surg Hand Surg. 2014 Jun;48(3):163-9. doi: 10.3109/2000656X.2013.859145. Epub 2013 Nov 21. PubMed 24256310 ↗
  • Orthopoulos G, Kudsi OY. Feasibility of Robotic-Assisted Transabdominal Preperitoneal Ventral Hernia Repair. J Laparoendosc Adv Surg Tech A. 2018 Apr;28(4):434-438. doi: 10.1089/lap.2017.0595. Epub 2018 Jan 2. PubMed 29293068 ↗
  • Sugiyama G, Chivukula S, Chung PJ, Alfonso A. Robot-Assisted Transabdominal Preperitoneal Ventral Hernia Repair. JSLS. 2015 Oct-Dec;19(4):e2015.00092. doi: 10.4293/JSLS.2015.00092. PubMed 26941547 ↗
  • Nahabedian MY. Management Strategies for Diastasis Recti. Semin Plast Surg. 2018 Aug;32(3):147-154. doi: 10.1055/s-0038-1661380. Epub 2018 Jul 24. PubMed 30046291 ↗
  • Beer GM, Schuster A, Seifert B, Manestar M, Mihic-Probst D, Weber SA. The normal width of the linea alba in nulliparous women. Clin Anat. 2009 Sep;22(6):706-11. doi: 10.1002/ca.20836. PubMed 19637295 ↗
  • Bellido Luque J, Bellido Luque A, Valdivia J, Suarez Grau JM, Gomez Menchero J, Garcia Moreno J, Guadalajara Jurado J. Totally endoscopic surgery on diastasis recti associated with midline hernias. The advantages of a minimally invasive approach. Prospective cohort study. Hernia. 2015 Jun;19(3):493-501. doi: 10.1007/s10029-014-1300-2. Epub 2014 Aug 21. PubMed 25142493 ↗
  • Driver VR, Hanft J, Fylling CP, Beriou JM; Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 2006 Jun;52(6):68-70, 72, 74 passim. PubMed 16799184 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2020 to primary completion in Oct 2022, 33 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 3, 2019
First posted
Nov 25, 2019
StartActual
Jan 2, 2020
Primary completionActual
Oct 2, 2022
CompletionEst.
Sep 25, 2023
Last update
Mar 3, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04176874
Responsible party
Sponsor
First posted
Nov 25, 2019
Start date
Jan 2, 2020
Primary completion
Oct 2, 2022
Completion
Sep 25, 2023 (estimated)
Last update
Mar 3, 2023

Study contacts

Barbara HERSANT, PhD
Contact
barbara.hersant@gmail.com
+ 33 1 49 81 45 33
Jean-Paul MENINGEAUD, PhD
Contact
meningaud@me.com
+33 1 49 81 45 33
Barbara HERSANT
principal investigator · APHP

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion